Division of Hematology and Oncology

color-enhanced cross section of tumor tissue

Study shows cancer vaccine blocks tumor progression at early lesion stage

The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

(iStock image)

VUMC researchers awarded $1.9 million for AI-driven cancer data extraction

The project seeks to reduce the time for clinical chart abstraction by 90% while maintaining human-level accuracy.

Patient Kathy Wilcox, here with her husband, John, is an avid flyer with an indefatigable zest for life; a quality that has not been shaken by her cancer diagnoses.

Vanderbilt-Ingram Cancer Center part of new ‘Rewriting Cancer’ series

Launched Sept. 17-19 during the World Cancer Congress in Geneva, Switzerland, “Rewriting Cancer” aims to enhance understanding and inspire audiences by exploring the most innovative, inclusive and impactful solutions for cancer prevention, diagnosis, treatment and care globally.

Clinical trial for rectal cancer subtype shows promise for less aggressive treatment

The findings were so promising that the clinical trial is being redesigned to investigate whether radiation treatment can also be avoided.

International trial introduces another curative option for sickle cell disease 

The therapy, haploidentical bone marrow transplant with thiotepa and posttransplant cyclophosphamide, is as safe and more affordable than the recently FDA-approved myeloablative gene therapy and gene editing treatments.

Automated algorithm predicts risk of blood clots in hospitalized patients

This new entry to the field works in the background to provide real-time risk assessments, with no manual inputs from health care providers required.

1 2 3 15